The shipment declared as “cosmetic weight loss product” was destined for an Ohio residence

U.S. Customs and Border Protection (CBP) officers at the port of Cincinnati seized two unapproved shipments of weight loss drugs, including one from a UK pharmacy, last month.

On 5 October, CBP officers seized a shipment declared as “cosmetic weight loss product” and found containing Mounjaro injectable pens of multiple doses (2.5mg, 5mg, and 7mg).

The shipment, arriving from a UK pharmacy and heading to a residence in Ohio, violated the Federal Food, Drug, and Cosmetic Act (FDCA), according to a U.S. Customs and Border Protection report.

Cincinnati CBP officers on 14 October intercepted another shipment, which was also destined for an Ohio residence.

This shipment from Hong Kong contained 20 vials of Semaglutide 10 mg and 150 Tirzepatide 30 mg, with a domestic value of $45,450.

LaFonda D. Sutton-Burke, Director of Field Operations-Chicago, stated that seizures involving these types of unapproved medications are a common occurrence that her officers see on a regular basis Read More…..